WuTC. What is the Real Clinical Significance of Carotid Sinus Hypersensitivity in Clinical Practice? A Dilemma Still Waiting for Answers. Arq. Bras. Cardiol. 2020;114(2):254-5.
Wu,Tan Chen. What is the Real Clinical Significance of Carotid Sinus Hypersensitivity in Clinical Practice? A Dilemma Still Waiting for Answers. Arq. Bras. Cardiol., v. 114, n. 2, p. 254-255, Feb. 2020.
Wu,T.C. (2020). What is the Real Clinical Significance of Carotid Sinus Hypersensitivity in Clinical Practice? A Dilemma Still Waiting for Answers. Arq. Bras. Cardiol.,114(2), 254-255.
Wu,Tan Chen. What is the Real Clinical Significance of Carotid Sinus Hypersensitivity in Clinical Practice? A Dilemma Still Waiting for Answers. Arq. Bras. Cardiol. [online]. 2020, vol. 114, n. 2, [cited 2025-09-07], pp.254-255. Available from: <https://abccardiol.org/en/short-editorial/what-is-the-real-clinical-significance-of-carotid-sinus-hypersensitivity-in-clinical-practice-a-dilemma-still-waiting-for-answers/>. ISSN 0066-782X.
Figure 1
Dyslipidemia as a central element in atherosclerotic cardiovascular disease. ASCVD: atherosclerotic cardiovascular disease; LDL-C: low-density lipoprotein cholesterol. Limitations of statin-based therapy (non-exhaustive) include suboptimal LDL-C goal attainment, statin-associated adverse effects that may affect adherence, and potential drug interactions. Residual risk reflects the involvement of multiple underlying pathways.
